Investigating genetic causes and treatments for CRX-linked retinopathies
Understanding and treating CRX-linked retinopathies
This study is looking at changes in a gene called CRX that can cause eye problems from a young age, using mice to learn more about how these changes affect vision, with the hope of finding new treatments that could help people with similar conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11089473 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic mutations in the CRX gene that lead to various forms of retinopathies, particularly those that manifest early in life. By creating mouse models that mimic these mutations, researchers aim to uncover the mechanisms behind the diseases and how they affect photoreceptor development and function. The study seeks to classify these mutations and explore potential treatment strategies based on the findings from these models. Patients may benefit from insights gained into their specific genetic conditions and potential future therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with CRX-linked retinopathies, particularly those with early-onset forms like Leber congenital amaurosis or cone rod dystrophy.
Not a fit: Patients with retinopathies caused by mutations outside of the CRX gene may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted therapies for patients suffering from CRX-linked retinopathies, improving their vision and quality of life.
How similar studies have performed: Previous research has shown success in understanding other genetic mutations related to retinopathies, suggesting that this approach could yield valuable insights as well.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Chen, Shiming — Washington University
- Study coordinator: Chen, Shiming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.